BetterScholar BetterScholar

J. Holder

Diabetes, Journal of Biological Chemistry, Chemistry and Biology, Journal of Clinical Investigation, FEBS Letters, Journal of Cell Science, Biochemical and Biophysical Research Communications - BBRC, TIPS - Trends in Pharmacological Sciences, Journal of Investigative Dermatology Show more
12
Role
Title
Level Year L/R
🐜 The Orphan G Protein-coupled Receptors GPR41 and GPR43 Are Activated by Propionate and Other Short Chain Carboxylic Acids*
22 auth. Andrew J. Brown, S. Goldsworthy, Ashley A. Barnes, Michelle M Eilert, Lili Tcheang, D. Daniels, A. Muir, M. Wigglesworth, I. Kinghorn, N. Fraser, ... N. Pike, J. Strum, K. Steplewski, P. Murdock, J. Holder, F. Marshall, P. Szekeres, Shelagh Wilson, D. Ignar, S. Foord, A. Wise, S. Dowell 		10 2003
10
🐜
🐒 Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
17 auth. M. Coghlan, A. Culbert, D. Cross, S. Corcoran, J. Yates, N. Pearce, G. Murphy, P. Carter, L. Roxbee Cox, D. Mills, ... M. J. Brown, D. Haigh, R. Ward, D. G. Smith, K. Murray, A. Reith, J. Holder 		9 2000
9
🐒
🐜 Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.
11 auth. Maria Adams, C. Montague, J. Prins, J. Holder, Stephen A. Smith, L. Sanders, ... J. Digby, C. P. Sewter, M. Lazar, V. Chatterjee, S. O’Rahilly 		9 1997
9
🐜
🐒 PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
G. Murphy, J. Holder 		8 2000
8
🐒
🐜 Insulin activates protein kinase B, inhibits glycogen synthase kinase‐3 and activates glycogen synthase by rapamycin‐insensitive pathways in skeletal muscle and adipose tissue
7 auth. D. Cross, P. Watt, M. Shaw, J. van der Kaay, C. Downes, J. Holder, ... P. Cohen 		7 1997
7
🐜
🐜 Peroxisome Proliferator-Activated Receptor (PPAR)-β/δ Stimulates Differentiation and Lipid Accumulation in Keratinocytes
19 auth. M. Schmuth, C. Haqq, W. Cairns, J. Holder, S. Dorsam, Sandra M. Chang, P. Lau, Ashley J. Fowler, G. Chuang, A. Moser, ... B. Brown, M. Man, Y. Uchida, K. Schoonjans, J. Auwerx, P. Chambon, T. Willson, P. Elias, K. Feingold 		7 2004
7
🐜
🐜 Role of PPAR γ and EGFR signalling in the urothelial terminal differentiation programme
8 auth. C. Varley, J. Stahlschmidt, Wen Lee, J. Holder, C. Diggle, P. Selby, ... L. Trejdosiewicz, J. Southgate 		7 2004
7
🐜
🐜 Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice.
7 auth. G. Moore, H. Chapman, J. Holder, C. Lister, V. Piercy, S. Smith, ... J. Clapham 		7 2001
7
🐜
🐜 Repeat Treatment of Obese Mice With BRL 49653, a New Potent Insulin Sensitizer, Enhances Insulin Action in White Adipocytes: Association With Increased Insulin Binding and Cell-Surface GLUT4 as Measured by Photoaffinity Labeling
9 auth. P. Young, M. Cawthorne, P. J. Coyle, J. Holder, G. Holman, I. Kozka, ... D. M. Kirkham, C. Lister, Stephen A. Smith 		7 1995
7
🐜
🐜 Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro.
9 auth. P. McTernan, A. Harte, L. A. Anderson, A. Green, Stephen A. Smith, J. Holder, ... A. Barnett, M. Eggo, Sudhesh Kumar 		7 2002
7
🐜
🐒 PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer.
G. Murphy, J. Holder 		7 2000
7
🐒
🐜 Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes.
19 auth. M. Schmuth, C. Haqq, W. Cairns, J. Holder, S. Dorsam, Sandra M. Chang, P. Lau, Ashley J. Fowler, G. Chuang, A. Moser, ... B. Brown, M. Man, Y. Uchida, K. Schoonjans, J. Auwerx, P. Chambon, T. Willson, P. Elias, K. Feingold 		6 2004
6
🐜